Science Explorer Back to mapMap
Discussion
Company · Kawasaki · Japan

OncoTherapy Science (Japan)

oncotherapy.co.jp/enROR OpenAlex
Research works
48
▼ 55% vs 2018-21
Citations
955
19.7 per fractional work
Top-10% rate
18.2%
all institutions 10.0%
Open access
47%
world 40%
International
55%
world 18%
OncoTherapy Science (Japan)

Not ranked overall: OncoTherapy Science (Japan) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OncoTherapy Science (Japan) work in?

In all years, 43% of research at OncoTherapy Science (Japan) is in Life Sciences, 28% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (29%), Medicine (28%), Immunology and Microbiology (12%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 21 fractional works · 43.1% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 28.6% of its workMolecular Biology: 13 fractional works · 26.8% of its workCell Biology: 1 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 6 fractional works · 11.6% of its workImmunology: 6 fractional works · 11.6% of its workNeuroscience: 1 fractional works · 1.6% of its workCognitive Neuroscience: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 1.2% of its workPlant Science: 1 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workHealth Sciences: 14 fractional works · 28.0% of its workMedicine: 13 fractional works · 27.7% of its workOncology: 5 fractional works · 10.7% of its workSurgery: 2 fractional works · 3.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.9% of its workPathology and Forensic Medicine: 1 fractional works · 1.7% of its workHematology: 1 fractional works · 1.5% of its workImmunology and Allergy: 1 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workEpidemiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.3% of its workPhysical Sciences: 12 fractional works · 23.8% of its workEngineering: 5 fractional works · 9.9% of its workElectrical and Electronic Engineering: 1 fractional works · 2.7% of its workOcean Engineering: 1 fractional works · 2.2% of its workAerospace Engineering: 1 fractional works · 2.0% of its workMechanics of Materials: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.9% of its workControl and Systems Engineering: 0 fractional works · 0.4% of its workCivil and Structural Engineering: 0 fractional works · 0.4% of its workComputational Mechanics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 2 fractional works · 4.7% of its workArtificial Intelligence: 1 fractional works · 2.1% of its workComputer Networks and Communications: 0 fractional works · 0.9% of its workHuman-Computer Interaction: 0 fractional works · 0.7% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPhysics and Astronomy: 2 fractional works · 4.6% of its workCondensed Matter Physics: 1 fractional works · 2.8% of its workAtomic and Molecular Physics, and Optics: 1 fractional works · 1.8% of its workMaterials Science: 1 fractional works · 2.9% of its workMaterials Chemistry: 1 fractional works · 1.6% of its workElectronic, Optical and Magnetic Materials: 1 fractional works · 1.3% of its workChemistry: 0 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workEarth and Planetary Sciences: 0 fractional works · 0.5% of its workAtmospheric Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workEnvironmental Engineering: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 5.1% of its workArts and Humanities: 1 fractional works · 1.4% of its workArcheology: 0 fractional works · 0.7% of its workPhilosophy: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 1 fractional works · 1.4% of its workManagement Information Systems: 0 fractional works · 1.0% of its workManagement of Technology and Innovation: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 1.2% of its workAnthropology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.7% of its workSocial Psychology: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.5% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.5% of its workALL ITS WORKOncoTherapyScience (Japan)48fractional works, all years
Life Sciences43%Physical Sciences24%Health Sciences28%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1428.6%
    2. Immunology and Microbiology611.6%
    3. Neuroscience11.6%
    4. Agricultural and Biological Sciences11.2%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Medicine1327.7%
    2. Health Professions00.3%
    1. Engineering59.9%
    2. Computer Science24.7%
    3. Physics and Astronomy24.6%
    4. Materials Science12.9%
    5. Chemistry01.0%
    6. Earth and Planetary Sciences00.5%
    7. Environmental Science00.2%
    1. Arts and Humanities11.4%
    2. Business, Management and Accounting11.4%
    3. Social Sciences11.2%
    4. Psychology00.7%
    5. Decision Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.01× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 10.64× its world share, 1 worksImmunology and Micro…Neuroscience: 1.90× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.58× its world share, 0 worksPharmacology, Toxico…Chemistry: 3.21× its world share, 0 worksChemistryComputer Science: 0.94× its world share, 0 worksComputer ScienceEngineering: 1.04× its world share, 1 worksEngineeringMaterials Science: 0.72× its world share, 0 worksMaterials SciencePhysics and Astronomy: 1.51× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.80× its world share, 0 worksHealth ProfessionsMedicine: 1.82× its world share, 2 worksMedicineDecision Sciences: 1.74× its world share, 0 worksDecision SciencesPsychology: 0.55× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.6×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Immunology and Microbiology10.64×1 works
  2. Pharmacology, Toxicology and Pharmaceutics3.58×0 works
  3. Chemistry3.21×0 works
  4. Biochemistry, Genetics and Molecular Biology2.01×1 works
  5. Neuroscience1.90×0 works
  6. Medicine1.82×2 works
  7. Decision Sciences1.74×0 works
  8. Physics and Astronomy1.51×0 works
  9. Engineering1.04×1 works
  10. Computer Science0.94×0 works
  11. Health Professions0.80×0 works
  12. Materials Science0.72×0 works
  13. Psychology0.55×0 works

Who are the top researchers at OncoTherapy Science (Japan)?

Ranked on the quality score, Yo Matsuo, Tetsuro Hikichi and Allan Goff lead among researchers whose main affiliation is OncoTherapy Science (Japan).

  1. 1 Yo Matsuo Japan · #3,053,131 worldwide 3.4k citations · 113 works
  2. 2 Tetsuro Hikichi Japan · #3,494,545 worldwide 312 citations · 22 works
  3. 3 Allan Goff Japan · #4,341,637 worldwide 160 citations · 23 works
All ranked researchers at OncoTherapy Science (Japan)

What are the most cited papers from OncoTherapy Science (Japan)?

The most cited paper from OncoTherapy Science (Japan) is "Functional analysis of Arabidopsis NCED6 and NCED9 genes indicates that ABA synthesized in the endosperm is involved in the induction of seed dormancy" (Valérie Lefebvre, Helen North, Anne Frey et al., 2006), with 504 citations. Next come "Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS" (156) and "Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer" (155).

Most cited papers
#PaperReleasedCitations
1 Functional analysis of Arabidopsis NCED6 and NCED9 genes indicates that ABA synthesized in the endosperm is involved in the induction of seed dormancy Valérie Lefebvre, Helen North, Anne Frey et al. · The Plant Journal 10 Jan 2006 504
2 Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno et al. · Clinical Cancer Research 13 Nov 2014 156
3 Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer Suyoun Chung, Hanae Suzuki, Takashi Miyamoto et al. · Oncotarget Open access 21 Dec 2012 155
4 Profiling of Hormones and Related Metabolites in Seed Dormancy and Germination Studies Mitsunori Seo, Yusuke Jikumaru, Yuji Kamiya · Methods in molecular biology Book chapter 2011 150
5 TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis Yo Matsuo, Jae‐Hyun Park, Takashi Miyamoto et al. · Science Translational Medicine 22 Oct 2014 140
All 60 most cited papers, with filters and sorting

Which keywords describe research at OncoTherapy Science (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Immunotherapy, Apoptosis, Antigen Presentation, Regulation, Oxidative Stress, Innate Immunity and Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer7▲ 9.9×13 topics
  2. Cancer Immunotherapy5▲ 72×3 topics
  3. Oxidative Stress5▲ 5.5×13 topics
  4. Apoptosis5▲ 24×6 topics
  5. Antigen Presentation4▲ 90×2 topics
  6. Regulation4▲ 14×3 topics
  7. Immunity4▲ 23×3 topics
  8. Innate Immunity4▲ 23×3 topics
  9. Metabolism4▲ 12×3 topics
  10. Dendritic Cells3▲ 61×1 topic
  11. FoxO Transcription Factors3▲ 168×1 topic
  12. Tumor Antigen3▲ 87×1 topic
  13. cell cycle regulation3▲ 1036×1 topic
  14. Tumor Microenvironment3▲ 18×4 topics
  15. Immunotherapy3▲ 9.5×6 topics
  16. Transcriptional Regulation2▲ 19×4 topics
  17. Cancer Progression2▲ 19×3 topics
  18. Nanowires2▲ 18×3 topics
  19. Chemotherapy2▲ 5.4×7 topics
  20. Immune Checkpoint Blockade2▲ 69×1 topic
  21. PD-1 and PD-L12▲ 69×1 topic
  22. Semiconductors2▲ 15×2 topics
  23. Prognostic Factors2▲ 7.7×7 topics
  24. Band Parameters2▲ 24×2 topics
  25. Neoadjuvant Therapy2▲ 13×4 topics
  26. Glycosylation1▲ 13×2 topics
  27. Inflammation1▲ 1.23×8 topics
  28. Cell Proliferation1▲ 29×2 topics
  29. III-Nitrides1▲ 63×1 topic
  30. Light-Emitting Diodes1▲ 22×1 topic
  31. Angiogenesis1▲ 5.8×4 topics
  32. CAR T Cells1▲ 55×1 topic
  33. Chimeric Antigen Receptor1▲ 55×1 topic
  34. Lymphoma1▲ 16×2 topics
  35. Cancer Therapy1▲ 3.5×5 topics
  36. Epigenetic Regulation1▲ 11×2 topics
  37. Photodetectors1▲ 24×2 topics
  38. Epigenetic Reprogramming1▲ 27×2 topics
  39. Epitaxial Growth1▲ 26×2 topics
  40. Metastasis1▲ 6.3×3 topics

Which research topics does OncoTherapy Science (Japan) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Acute Myeloid Leukemia Research and Protein Degradation and Inhibitors.

Cancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksClick Chemistry and Applications: 0 fractional worksFerroelectric and Piezoelectric Materials: 0 fractional worksInteractive and Immersiv…0Interactive and Immersive Displays: 0 fractional worksVirtual Reality Applications and Impacts: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksAdvanced MEMS and NEMS T…0Advanced MEMS and NEMS Technologies: 0 fractional works
OncologyImmunologyHematologyMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
  2. 2 Immunotherapy and Immune Responses Immunology 0 works
  3. 3 Acute Myeloid Leukemia Research Hematology 0 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 0 works
  5. 5 Click Chemistry and Applications Organic Chemistry 0 works
  6. 6 Ferroelectric and Piezoelectric Materials Materials Chemistry 0 works
  7. 7 Interactive and Immersive Displays Human-Computer Interaction 0 works
  8. 8 Virtual Reality Applications and Impacts Human-Computer Interaction 0 works
  9. 9 Cancer Cells and Metastasis Oncology 0 works
  10. 10 Advanced MEMS and NEMS Technologies Electrical and Electronic Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.2%not open52.8%

World: 40% of research is openly available.

with international co-authors54.6%domestic only45.4%

World: 18% is written across borders.

How has OncoTherapy Science (Japan)'s research output changed?

Output in 2022-2025 was 55% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is OncoTherapy Science (Japan) as a percentage of every work published that year, 0.000014% in 2024.

still counting0.000050%0.00010%0.00015%OncoTherapy Science (Japan)0.000016% in 2025200020102020

Fractional works of OncoTherapy Science (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Kawasaki

All research institutions in Kawasaki

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OncoTherapy Science (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.